GPPL RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Active ingredient:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

rizatriptan benzoate

Pharmaceutical form:

Tablet, orally disintegrating

Composition:

Excipient Ingredients: hypromellose; mannitol; silicon dioxide; crospovidone; acesulfame potassium; colloidal anhydrous silica; sodium stearylfumarate; ethylcellulose; Flavour

Administration route:

Sublingual

Units in package:

6, 2, 3

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

for acute treatment of migraine attacks with or without aura.

Product summary:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Registered

Authorization date:

2015-03-20